Skip to main content
Clinical Trials/NCT00311064
NCT00311064
Withdrawn
Phase 1

Inflammatory Response and Pregnancy Outcome in Women With Type 2 Diabetes or Only Overweight. The Influence of Physical Activity

Rigshospitalet, Denmark1 site in 1 country280 target enrollmentMarch 2006
ConditionsInflammation

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Inflammation
Sponsor
Rigshospitalet, Denmark
Enrollment
280
Locations
1
Primary Endpoint
perinatal mortality
Status
Withdrawn
Last Updated
18 years ago

Overview

Brief Summary

Purpose:

The purpose of this study is to determine if disturbances in cytokines or factors of the metabolic syndrome, can predict complications in pregnancy, birth, and the perinatal period in pregnant women with type 2 diabetes or who are overweight. At the same time we, the investigators at Rigshospitalet, want to determine if physical activity in the overweight pregnant woman can influence these factors in a favourable way and, with that, improve the progress of pregnancy and birth.

Detailed Description

Material and Method: This study falls in two fields: First 80 pregnant women with type 2 diabetes are followed with determination of cytokines and factors of the metabolic syndrome throughout the pregnancy. The correlation between these variables and the pregnancy and delivery progress is evaluated. 280 overweight (body mass index \[BMI\] \> 30 kg/m2) pregnant women with no medical conditions are examined in the same way. The women are randomized in week 14 to either continue their habitual physical activity or to elevate it by participating in a training program with other pregnant women 3 times weekly. Both groups will get blood samples taken during fasting approximately 50 ml 3-4 times during the pregnancy.

Registry
clinicaltrials.gov
Start Date
March 2006
End Date
January 2008
Last Updated
18 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • BMI \> 30 kg/m2
  • BMI \< 45 kg/m2
  • Over 18 years of age
  • No earlier preterm delivery (before 37)
  • Singleton pregnancy
  • 14 weeks +/- 1 week of gestation

Exclusion Criteria

  • BMI \> 45 kg/m2
  • Earlier preterm delivery (before 37)
  • Not singleton pregnancy
  • Medically treated diseases

Outcomes

Primary Outcomes

perinatal mortality

congenital malformations and preeclampsia

gestational hypertension and gestational diabetes mellitus (GDM)

preterm delivery

too large infants (> 2 standard deviation [SD])

Secondary Outcomes

  • delivery by caesarian section
  • induction of labour

Study Sites (1)

Loading locations...

Similar Trials